291 related articles for article (PubMed ID: 12101116)
1. Rectal epithelial apoptosis does not predict response to sulindac treatment or polyp development in presymptomatic familial adenomatous polyposis patients.
Keller JJ; Offerhaus GJ; Hylind LM; Giardiello FM
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):670-1. PubMed ID: 12101116
[No Abstract] [Full Text] [Related]
2. Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis.
Winde G; Schmid KW; Brandt B; Müller O; Osswald H
Dis Colon Rectum; 1997 Oct; 40(10):1156-68; discussion 1168-9. PubMed ID: 9336110
[TBL] [Abstract][Full Text] [Related]
3. Sulindac in familial adenomatous polyposis: evaluation by nuclear morphometry.
Fernández-López F; Conde-Freire R; Cadarso-Suárez C; García-Iglesias J; Puente-Domínguez JL; Potel-Lesquereux J
Eur J Surg; 2001 May; 167(5):375-81. PubMed ID: 11419555
[TBL] [Abstract][Full Text] [Related]
4. Colonic aberrant crypts in children with familial adenomatous polyposis.
Drut R
Int J Surg Pathol; 2007 Jul; 15(3):258-61. PubMed ID: 17652532
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC;
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane.
Kishimoto Y; Yashima K; Morisawa T; Ohishi T; Marumoto A; Sano A; Idobe-Fujii Y; Miura N; Shiota G; Murawaki Y; Hasegawa J
J Cancer Res Clin Oncol; 2002 Nov; 128(11):589-95. PubMed ID: 12458338
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis.
van Stolk R; Stoner G; Hayton WL; Chan K; DeYoung B; Kresty L; Kemmenoe BH; Elson P; Rybicki L; Church J; Provencher K; McLain D; Hawk E; Fryer B; Kelloff G; Ganapathi R; Budd GT
Clin Cancer Res; 2000 Jan; 6(1):78-89. PubMed ID: 10656435
[TBL] [Abstract][Full Text] [Related]
8. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis.
Pasricha PJ; Bedi A; O'Connor K; Rashid A; Akhtar AJ; Zahurak ML; Piantadosi S; Hamilton SR; Giardiello FM
Gastroenterology; 1995 Sep; 109(3):994-8. PubMed ID: 7657130
[TBL] [Abstract][Full Text] [Related]
9. Effect of indomethacin suppositories on rectal polyposis in patients with familial adenomatous polyposis.
Hirota C; Iida M; Aoyagi K; Matsumoto T; Tada S; Yao T; Fujishima M
Cancer; 1996 Oct; 78(8):1660-5. PubMed ID: 8859177
[TBL] [Abstract][Full Text] [Related]
10. In vivo observation of the ileal microadenoma in familial adenomatous polyposis.
Matsumoto T; Iida M; Mizuno M; Shimizu M; Nakamura S; Fujishima M
Am J Gastroenterol; 1999 Nov; 94(11):3354-8. PubMed ID: 10566743
[TBL] [Abstract][Full Text] [Related]
11. [Collagen colitis, adenomatous polyp and colon carcinoma].
Walker S; Rühl U; Butters M
Z Gastroenterol; 1998 Mar; 36(3):XXII-XXIII. PubMed ID: 9577912
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
[TBL] [Abstract][Full Text] [Related]
13. Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac.
Keller JJ; Offerhaus GJ; Polak M; Goodman SN; Zahurak ML; Hylind LM; Hamilton SR; Giardiello FM
Gut; 1999 Dec; 45(6):822-8. PubMed ID: 10562579
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.
Nugent KP; Farmer KC; Spigelman AD; Williams CB; Phillips RK
Br J Surg; 1993 Dec; 80(12):1618-9. PubMed ID: 8298943
[TBL] [Abstract][Full Text] [Related]
15. Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa.
Holt PR; Bresalier RS; Ma CK; Liu KF; Lipkin M; Byrd JC; Yang K
Cancer; 2006 Jan; 106(2):287-96. PubMed ID: 16353199
[TBL] [Abstract][Full Text] [Related]
16. Oral calcium inhibits rectal epithelial proliferation in familial adenomatous polyposis.
Thomas MG; Thomson JP; Williamson RC
Br J Surg; 1993 Apr; 80(4):499-501. PubMed ID: 8388307
[TBL] [Abstract][Full Text] [Related]
17. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.
Koornstra JJ; Rijcken FE; Oldenhuis CN; Zwart N; van der Sluis T; Hollema H; deVries EG; Keller JJ; Offerhaus JA; Giardiello FM; Kleibeuker JH
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1608-12. PubMed ID: 16030090
[TBL] [Abstract][Full Text] [Related]
18. Sulindac in familial adenomatous polyposis.
Levy R
N Engl J Med; 2002 Aug; 347(8):615. PubMed ID: 12192027
[No Abstract] [Full Text] [Related]
19. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment.
Spagnesi MT; Tonelli F; Dolara P; Caderni G; Valanzano R; Anastasi A; Bianchini F
Gastroenterology; 1994 Feb; 106(2):362-6. PubMed ID: 8299902
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype correlations as a guide in the management of familial adenomatous polyposis.
Nieuwenhuis MH; Mathus-Vliegen LM; Slors FJ; Griffioen G; Nagengast FM; Schouten WR; Kleibeuker JH; Vasen HF
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):374-8. PubMed ID: 17368237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
